These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32299591)

  • 1. AntimiR-21 Prevents Myocardial Dysfunction in a Pig Model of Ischemia/Reperfusion Injury.
    Hinkel R; Ramanujam D; Kaczmarek V; Howe A; Klett K; Beck C; Dueck A; Thum T; Laugwitz KL; Maegdefessel L; Weber C; Kupatt C; Engelhardt S
    J Am Coll Cardiol; 2020 Apr; 75(15):1788-1800. PubMed ID: 32299591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction.
    Hinkel R; Batkai S; Bähr A; Bozoglu T; Straub S; Borchert T; Viereck J; Howe A; Hornaschewitz N; Oberberger L; Jurisch V; Kozlik-Feldmann R; Freudenthal F; Ziegler T; Weber C; Sperandio M; Engelhardt S; Laugwitz KL; Moretti A; Klymiuk N; Thum T; Kupatt C
    J Am Coll Cardiol; 2021 Jun; 77(23):2923-2935. PubMed ID: 34112319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.
    Bernardo BC; Gao XM; Winbanks CE; Boey EJ; Tham YK; Kiriazis H; Gregorevic P; Obad S; Kauppinen S; Du XJ; Lin RC; McMullen JR
    Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17615-20. PubMed ID: 23047694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound and Microbubble-targeted Delivery of a microRNA Inhibitor to the Heart Suppresses Cardiac Hypertrophy and Preserves Cardiac Function.
    Kopechek JA; McTiernan CF; Chen X; Zhu J; Mburu M; Feroze R; Whitehurst DA; Lavery L; Cyriac J; Villanueva FS
    Theranostics; 2019; 9(23):7088-7098. PubMed ID: 31660088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of MicroRNA miR-1954 Promotes Cardiac Remodeling and Fibrosis.
    Chiasson V; Takano APC; Guleria RS; Gupta S
    J Am Heart Assoc; 2019 Nov; 8(21):e012880. PubMed ID: 31640463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases.
    Ooi JYY; Bernardo BC; Singla S; Patterson NL; Lin RCY; McMullen JR
    RNA Biol; 2017 May; 14(5):500-513. PubMed ID: 27124358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-21-Dependent Macrophage-to-Fibroblast Signaling Determines the Cardiac Response to Pressure Overload.
    Ramanujam D; Schön AP; Beck C; Vaccarello P; Felician G; Dueck A; Esfandyari D; Meister G; Meitinger T; Schulz C; Engelhardt S
    Circulation; 2021 Apr; 143(15):1513-1525. PubMed ID: 33550817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model.
    Hinkel R; Penzkofer D; Zühlke S; Fischer A; Husada W; Xu QF; Baloch E; van Rooij E; Zeiher AM; Kupatt C; Dimmeler S
    Circulation; 2013 Sep; 128(10):1066-75. PubMed ID: 23897866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single intracoronary injection of encapsulated antagomir-92a promotes angiogenesis and prevents adverse infarct remodeling.
    Bellera N; Barba I; Rodriguez-Sinovas A; Ferret E; Asín MA; Gonzalez-Alujas MT; Pérez-Rodon J; Esteves M; Fonseca C; Toran N; Garcia Del Blanco B; Pérez A; Garcia-Dorado D
    J Am Heart Assoc; 2014 Sep; 3(5):e000946. PubMed ID: 25240056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling.
    Sassi Y; Avramopoulos P; Ramanujam D; Grüter L; Werfel S; Giosele S; Brunner AD; Esfandyari D; Papadopoulou AS; De Strooper B; Hübner N; Kumarswamy R; Thum T; Yin X; Mayr M; Laggerbauer B; Engelhardt S
    Nat Commun; 2017 Nov; 8(1):1614. PubMed ID: 29158499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-31 promotes adverse cardiac remodeling and dysfunction in ischemic heart disease.
    Martinez EC; Lilyanna S; Wang P; Vardy LA; Jiang X; Armugam A; Jeyaseelan K; Richards AM
    J Mol Cell Cardiol; 2017 Nov; 112():27-39. PubMed ID: 28865712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-378 suppresses myocardial fibrosis through a paracrine mechanism at the early stage of cardiac hypertrophy following mechanical stress.
    Yuan J; Liu H; Gao W; Zhang L; Ye Y; Yuan L; Ding Z; Wu J; Kang L; Zhang X; Wang X; Zhang G; Gong H; Sun A; Yang X; Chen R; Cui Z; Ge J; Zou Y
    Theranostics; 2018; 8(9):2565-2582. PubMed ID: 29721099
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy.
    Bernardo BC; Nguyen SS; Winbanks CE; Gao XM; Boey EJ; Tham YK; Kiriazis H; Ooi JY; Porrello ER; Igoor S; Thomas CJ; Gregorevic P; Lin RC; Du XJ; McMullen JR
    FASEB J; 2014 Dec; 28(12):5097-110. PubMed ID: 25145628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.
    Bernardo BC; Ooi JY; Matsumoto A; Tham YK; Singla S; Kiriazis H; Patterson NL; Sadoshima J; Obad S; Lin RC; McMullen JR
    J Physiol; 2016 Oct; 594(20):5959-5974. PubMed ID: 27270487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Cardiac Regenerative Ability of Stem Cells After Ischemia-Reperfusion Injury: Role of Human CD34+ Cells Deficient in MicroRNA-377.
    Joladarashi D; Garikipati VNS; Thandavarayan RA; Verma SK; Mackie AR; Khan M; Gumpert AM; Bhimaraj A; Youker KA; Uribe C; Suresh Babu S; Jeyabal P; Kishore R; Krishnamurthy P
    J Am Coll Cardiol; 2015 Nov; 66(20):2214-2226. PubMed ID: 26564600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of heart failure with preserved ejection fraction (HFpEF): reexamining microRNA-21 inhibition in the era of oligonucleotide-based therapeutics.
    Ben-Nun D; Buja LM; Fuentes F
    Cardiovasc Pathol; 2020; 49():107243. PubMed ID: 32629211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload.
    Bernardo BC; Nguyen SS; Gao XM; Tham YK; Ooi JY; Patterson NL; Kiriazis H; Su Y; Thomas CJ; Lin RC; Du XJ; McMullen JR
    Sci Rep; 2016 Mar; 6():22442. PubMed ID: 26928825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice.
    Patrick DM; Montgomery RL; Qi X; Obad S; Kauppinen S; Hill JA; van Rooij E; Olson EN
    J Clin Invest; 2010 Nov; 120(11):3912-6. PubMed ID: 20978354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of miR-21 is involved in direct actions of ursolic acid on the heart: implications for cardiac fibrosis and hypertrophy.
    Dong X; Liu S; Zhang L; Yu S; Huo L; Qile M; Liu L; Yang B; Yu J
    Cardiovasc Ther; 2015 Aug; 33(4):161-7. PubMed ID: 25903305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M2b Macrophages Regulate Cardiac Fibroblast Activation and Alleviate Cardiac Fibrosis After Reperfusion Injury.
    Yue Y; Huang S; Wang L; Wu Z; Liang M; Li H; Lv L; Li W; Wu Z
    Circ J; 2020 Mar; 84(4):626-635. PubMed ID: 32161201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.